13F HOLDINGS REPORT
Ikarian Capital, LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001420506-23-000695
Total Value
$414.5M
Positions
86
Other Managers
0
Confidential Omitted
No
Holdings (86)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MADRIGAL PHARMACEUTICALS INC | MDGL | 300,000 | $87.1M | 21.01% |
| 2 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 288,926 | $31.8M | 7.67% |
| 3 | IMMUNOVANT INC | IMVT | 966,700 | $17.2M | 4.14% |
| 4 | KRYSTAL BIOTECH INC | KRYS | 165,900 | $13.1M | 3.17% |
| 5 | VAXCYTE INC | PCVX | 250,000 | $12.0M | 2.89% |
| 6 | CELLDEX THERAPEUTICS INC NEW | CLDX | 267,476 | $11.9M | 2.88% |
| 7 | ESPERION THERAPEUTICS INC NE | ESPR | 1,891,147 | $11.8M | 2.84% |
| 8 | BIOHAVEN LTD | BHVN | 837,500 | $11.6M | 2.80% |
| 9 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 100,000 | $11.0M | 2.65% |
| 10 | HORIZON THERAPEUTICS PUB L | G46188101 | 89,219 | $10.2M | 2.45% |
| 11 | ASTRIA THERAPEUTICS INC | 04635X102 | 675,176 | $10.1M | 2.43% |
| 12 | ALTIMMUNE INC | ALT | 577,400 | $9.5M | 2.29% |
| 13 | SPDR SER TR | 78464A870 | 100,000 | $8.3M | 2.00% |
| 14 | SPDR SER TR | 78464A870 | 100,000 | $8.3M | 2.00% |
| 15 | ESPERION THERAPEUTICS INC NE | ESPR | 1,296,900 | $8.1M | 1.95% |
| 16 | IVERIC BIO INC | 46583P102 | 377,021 | $8.1M | 1.95% |
| 17 | REATA PHARMACEUTICALS INC | 75615P103 | 201,200 | $7.6M | 1.84% |
| 18 | TERNS PHARMACEUTICALS INC | TERN | 737,319 | $7.5M | 1.81% |
| 19 | BELLUS HEALTH INC NEW | 07987C204 | 885,334 | $7.3M | 1.76% |
| 20 | VERONA PHARMA PLC | 925050106 | 255,131 | $6.7M | 1.61% |
| 21 | XENON PHARMACEUTICALS INC | XENE | 160,486 | $6.3M | 1.53% |
| 22 | DECIPHERA PHARMACEUTICALS IN | 24344T101 | 367,119 | $6.0M | 1.45% |
| 23 | ARCUS BIOSCIENCES INC | RCUS | 283,100 | $5.9M | 1.41% |
| 24 | 89BIO INC | 282559103 | 454,000 | $5.8M | 1.39% |
| 25 | BLUEBIRD BIO INC | 09609G100 | 812,628 | $5.6M | 1.36% |
| 26 | BIOXCEL THERAPEUTICS INC | BTAI | 250,000 | $5.4M | 1.30% |
| 27 | VERONA PHARMA PLC | 925050106 | 200,000 | $5.2M | 1.26% |
| 28 | ACADIA PHARMACEUTICALS INC | ACAD | 325,000 | $5.2M | 1.25% |
| 29 | MIRATI THERAPEUTICS INC | 60468T105 | 108,100 | $4.9M | 1.18% |
| 30 | ALTIMMUNE INC | ALT | 273,432 | $4.5M | 1.09% |
| 31 | KEZAR LIFE SCIENCES INC | KZR | 629,986 | $4.4M | 1.07% |
| 32 | TRACON PHARMACEUTICALS INC | 89237H209 | 2,765,530 | $4.1M | 0.99% |
| 33 | ARDELYX INC | ARDX | 1,378,825 | $3.9M | 0.95% |
| 34 | AEROVATE THERAPEUTICS INC | 008064107 | 127,921 | $3.7M | 0.90% |
| 35 | SAREPTA THERAPEUTICS INC | SRPT | 28,324 | $3.7M | 0.89% |
| 36 | ARVINAS INC | ARVN | 100,000 | $3.4M | 0.83% |
| 37 | SEAGEN INC | SE | 25,000 | $3.2M | 0.78% |
| 38 | ARCUS BIOSCIENCES INC | RCUS | 137,987 | $2.9M | 0.69% |
| 39 | SAGE THERAPEUTICS INC | 78667J108 | 67,805 | $2.6M | 0.62% |
| 40 | ASTRIA THERAPEUTICS INC | 04635X102 | 171,100 | $2.5M | 0.61% |
| 41 | MERUS N V | N5749R100 | 156,000 | $2.4M | 0.58% |
| 42 | VIKING THERAPEUTICS INC | VKTX | 203,156 | $1.9M | 0.46% |
| 43 | MILESTONE PHARMACEUTICALS IN | MIST | 460,416 | $1.8M | 0.44% |
| 44 | GERON CORP | GERN | 650,000 | $1.6M | 0.38% |
| 45 | PROQR THRAPEUTICS N V | N71542109 | 422,625 | $1.6M | 0.38% |
| 46 | ACUMEN PHARMACEUTICALS INC | ABOS | 254,945 | $1.4M | 0.33% |
| 47 | ARK ETF TR | 00214Q302 | 46,462 | $1.3M | 0.32% |
| 48 | LYRA THERAPEUTICS INC | LYRA | 343,685 | $1.1M | 0.26% |
| 49 | INTERCEPT PHARMACEUTICALS IN | INTR | 85,200 | $1.1M | 0.25% |
| 50 | POINT BIOPHARMA GLOBAL INC | 730541109 | 139,565 | $1.0M | 0.25% |
| 51 | CHEMOMAB THERAPEUTICS LTD | CMMB | 313,392 | $1.0M | 0.24% |
| 52 | IMMUNIC INC | IMUX | 650,000 | $910,000 | 0.22% |
| 53 | COGENT BIOSCIENCES INC | COGT | 62,766 | $725,576 | 0.18% |
| 54 | OCULAR THERAPEUTIX INC | OCUL | 200,000 | $562,000 | 0.14% |
| 55 | ELEDON PHARMACEUTICALS INC | ELDN | 221,830 | $514,645 | 0.12% |
| 56 | PROTARA THERAPEUTICS INC | TARA | 188,664 | $505,619 | 0.12% |
| 57 | BIOGEN INC | BIIB | 1,800 | $498,456 | 0.12% |
| 58 | DESIGN THERAPEUTICS INC | DSGN | 48,500 | $497,610 | 0.12% |
| 59 | AUTOLUS THERAPEUTICS PLC | AUTL | 260,087 | $494,166 | 0.12% |
| 60 | IMMUNOVANT INC | IMVT | 26,200 | $465,050 | 0.11% |
| 61 | IMMATICS N.V | IMTX | 49,031 | $427,060 | 0.10% |
| 62 | ANEBULO PHARMACEUTICALS INC | ANEB | 156,203 | $374,888 | 0.09% |
| 63 | RENEO PHARMACEUTICALS INC | 75974E103 | 155,819 | $363,059 | 0.09% |
| 64 | GERON CORP | GERN | 150,000 | $363,000 | 0.09% |
| 65 | PRAXIS PRECISION MEDICINES I | PRAX | 150,000 | $357,000 | 0.09% |
| 66 | X4 PHARMACEUTICALS INC | XFOR | 349,133 | $346,689 | 0.08% |
| 67 | BELLICUM PHARMACEUTICALS INC | 079481404 | 448,101 | $322,633 | 0.08% |
| 68 | BRAINSTORM CELL THERAPEUTICS | BCLI | 189,935 | $311,494 | 0.08% |
| 69 | CABALETTA BIO INC | CABA | 30,286 | $280,145 | 0.07% |
| 70 | BIOGEN INC | BIIB | 962 | $266,398 | 0.06% |
| 71 | SYNLOGIC INC | SYBX | 306,757 | $233,135 | 0.06% |
| 72 | RELMADA THERAPEUTICS INC | RLMD | 65,491 | $228,563 | 0.06% |
| 73 | CONNECT BIOPHARMA HLDGS LTD | CNTB | 219,501 | $190,482 | 0.05% |
| 74 | ASLAN PHARMACEUTICALS LTD | 04522R101 | 820,455 | $151,446 | 0.04% |
| 75 | ARK ETF TR | 00214Q104 | 4,519 | $141,174 | 0.03% |
| 76 | SATSUMA PHARMACEUTICALS INC | 80405P107 | 136,059 | $122,453 | 0.03% |
| 77 | DESIGN THERAPEUTICS INC | DSGN | 11,568 | $118,689 | 0.03% |
| 78 | FINCH THERAPEUTICS GROUP INC | FNCHQ | 237,553 | $114,026 | 0.03% |
| 79 | SPECTRUM PHARMACEUTICALS INC | 84763A108 | 176,980 | $65,217 | 0.02% |
| 80 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 397,168 | $43,888 | 0.01% |
| 81 | TRICIDA INC | 89610F101 | 145,700 | $22,277 | 0.01% |
| 82 | MADRIGAL PHARMACEUTICALS INC | MDGL | 75 | $21,770 | 0.01% |
| 83 | GOSSAMER BIO INC | GOSS | 6,100 | $13,237 | 0.00% |
| 84 | DESIGN THERAPEUTICS INC | DSGN | 800 | $8,208 | 0.00% |
| 85 | ERYTECH PHARMA | 29604W108 | 3,019 | $1,185 | 0.00% |
| 86 | CHINOOK THERAPEUTICS INC | 16961L106 | 283,464 | $0 | 0.00% |